Pnc Financial Services Group, Inc. Igm Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $150 Billion
- Q2 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 23 shares of IGMS stock, worth $396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 7
228.57%
Holding current value
$396
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IGMS
# of Institutions
89Shares Held
21.4MCall Options Held
39.5KPut Options Held
16.5K-
Baker Bros. Advisors LP New York, NY4.09MShares$70.6 Million0.37% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.08MShares$70.3 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N43.33MShares$57.5 Million1.45% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$53 Million1.38% of portfolio
-
Goldman Sachs Group Inc New York, NY1.33MShares$23 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $500M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...